Regeneron Pharmaceuticals REGN
NASDAQ REGN
$796.02 -5.80 (-0.72%)
At close: Sep 24, 2026 · 4:00 PM EDT

Regeneron Pharmaceuticals (REGN) Revenue (2009 - 2026)

Regeneron Pharmaceuticals (REGN) posted Revenue of $4.3 billion for Q2 2026, up 19.01% on a QoQ basis from $3.6 billion in Q1 2026, and up 16.73% year-over-year from $3.7 billion in Q2 2025.

Analysis

Regeneron Pharmaceuticals (REGN) Revenue (2009 - 2026) Analysis & Trends

Regeneron Pharmaceuticals has reported Revenue for 18 years, with the latest figure at $4.3 billion in Q2 2026.

  • On a quarterly basis, Revenue rose 16.73% year-over-year to $4.3 billion in Q2 2026; TTM through Jun 2026 was $15.5 billion, a 9.29% increase from a year earlier, with the FY2025 full-year figure at $14.3 billion, up 0.99% from the prior year.
  • Revenue was $4.3 billion for Q2 2026 at Regeneron Pharmaceuticals, up from $3.6 billion in the prior quarter.
  • The five-year high for Revenue was $4.3 billion in Q2 2026, with the low at $100.0 million in Q4 2022.
  • Average Revenue over 5 years is $3.2 billion, with a median of $3.4 billion recorded in 2023.
  • The sharpest annual moves came in 2022 and 2023: Revenue plunged 97.98% in 2022, then surged 3334.3% in 2023.
  • Over 5 years, Revenue stood at $100.0 million in 2022, then soared by 3334.3% to $3.4 billion in 2023, then advanced by 10.33% to $3.8 billion in 2024, then advanced by 2.51% to $3.9 billion in 2025, then rose by 10.46% to $4.3 billion in 2026.
  • The last three Revenue figures came in at $4.3 billion (Q2 2026), $3.6 billion (Q1 2026), and $3.9 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 25.31 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 16.99 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn 15.38 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 7.80 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 3.33 Bn
10 Regeneron Pharmaceuticals 82.43 Bn 74.43 Bn 3.93 Bn 4.29 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.29 Bn
Mar 31, 2026 3.61 Bn
Dec 31, 2025 3.88 Bn
Sep 30, 2025 3.75 Bn
Jun 30, 2025 3.68 Bn
Mar 31, 2025 3.03 Bn
Dec 31, 2024 3.79 Bn
Sep 30, 2024 3.72 Bn
Jun 30, 2024 3.55 Bn
Mar 31, 2024 3.15 Bn
Dec 31, 2023 3.43 Bn
Sep 30, 2023 3.36 Bn
Jun 30, 2023 3.16 Bn
Mar 31, 2023 3.16 Bn
Dec 31, 2022 100.00 Mn
Sep 30, 2022 2.94 Bn
Jun 30, 2022 2.86 Bn
Mar 31, 2022 2.97 Bn
Dec 31, 2021 4.95 Bn
Sep 30, 2021 3.45 Bn
API Access

Regeneron Pharmaceuticals Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=REGN&period=max&api_key=YOUR_API_KEY